HCV monoclonal antibody regulatory update

INNX's GENimmune N.V. subsidiary received Orphan Drug designation from EMEA's COMP for a recombinant human hepatitis C monoclonal antibody to prevent hepatitis C virus (HCV) re-infection after liver t...